Effects of polyphenols on cancer cell progression mediated by inhibition of cyclin-dependent kinases (CDKs): the emerging drug targets in cancer

No abstract is available for this paper.

• Publication year

  2025

• Venue

  Archives of pharmacal research

• Publication date

  2025-11-10

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1007/s12272-025-01578-6PMID 41212496
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Anticancer Perspective of Tangeretin: A Small Review

  2025cited by this paper
• Advancements in delivery systems for dietary polyphenols in enhancing radioprotection effects: challenges and opportunities

  2025cited by this paper
• Integrated in-silico approach to explore the therapeutic potential of RNAs and druggable polyphenols to mine alternative breast cancer therapeutic strategies targeting cancer hallmarks

  2025cited by this paper
• The increasing global burden of cancer: implications for anaesthesia and peri‐operative medicine

  2025cited by this paper
• Targeting CDK4/6 in breast cancer

  2025cited by this paper
• Resistance mechanisms and therapeutic strategies of CDK4 and CDK6 kinase targeting in cancer

  2025cited by this paper
• Cyclin-dependent protein kinases and cell cycle regulation in biology and disease

  2025cited by this paper
• Synergistic chemotherapy and immunomodulatory effects of Quercetin in cancer: a review

  2025cited by this paper
• Gallic acid ameliorates endometrial hyperplasia through the inhibition of the PI3K/AKT pathway and the down-regulation of cyclin D1 expression.

  2024cited by this paper
• Biochanin A Induces Apoptosis in MCF‐7 Breast Cancer Cells through Mitochondrial Pathway and Pi3K/AKT Inhibition

  2024cited by this paper
• Breast cancer statistics 2024

  2024cited by this paper
• Cancer therapy by cyclin-dependent kinase inhibitors (CDKIs): bench to bedside

  2024cited by this paper
• Synergistic Mechanisms of Selected Polyphenols in Overcoming Chemoresistance and Enhancing Chemosensitivity in Colorectal Cancer

  2024influential reference
• Quercetin inhibits the epithelial-mesenchymal transition and reverses CDK4/6 inhibitor resistance in breast cancer by regulating circHIAT1/miR-19a-3p/CADM2 axis

  2024cited by this paper
• Caffeic acid hinders the proliferation and migration through inhibition of IL-6 mediated JAK-STAT-3 signaling axis in human prostate cancer

  2024cited by this paper
• Cancer statistics, 2024

  2024influential reference
• Acacetin inhibited non-small-cell lung cancer (NSCLC) cell growth via upregulating miR-34a in vitro and in vivo

  2024cited by this paper
• Naringin Induces ROS‐Stimulated G1 Cell‐Cycle Arrest and Apoptosis in Nasopharyngeal Carcinoma Cells

  2024cited by this paper
• A Molecular Dynamic Simulation, Structural Analysis, and Ex Vivo Insights into the P-glycoprotein-Mediated Interactions of Dietary Polyphenols with Cyclin-dependent Kinase Inhibitors: A Potential Strategy to Counteract Drug Efflux.

  2024cited by this paper
• A systematic review on understanding the mechanistic pathways and clinical aspects of natural CDK inhibitors on cancer progression.: Unlocking cellular and biochemical mechanisms.

  2024cited by this paper
• Polyphenols and metabolism: from present knowledge to future challenges

  2024cited by this paper
• Synthetic derivatives of natural cinnamic acids as potential anti‐colorectal cancer agents

  2023cited by this paper
• Baicalein as Promising Anticancer Agent: A Comprehensive Analysis on Molecular Mechanisms and Therapeutic Perspectives

  2023cited by this paper
• Cyclin-dependent kinases in cancer: Role, regulation, and therapeutic targeting.

  2023cited by this paper
• The potential role of formononetin in cancer treatment: An updated review.

  2023cited by this paper
• Role of NF-κB/ICAM-1, JAK/STAT-3, and apoptosis signaling in the anticancer effect of tangeretin against urethane-induced lung cancer in BALB/c mice.

  2023cited by this paper
• Chrysin a promising anticancer agent: recent perspectives

  2023influential reference
• The Cyclin-dependent kinase 1: more than a cell cycle regulator

  2023cited by this paper
• The Regulation of Cyclins and Cyclin-Dependent Kinases in the Development of Gastric Cancer

  2023cited by this paper
• Pharmacological Mechanisms and Clinical Applications of Curcumin: Update

  2023cited by this paper
• Targets Involved in the Anti-Cancer Activity of Quercetin in Breast, Colorectal and Liver Neoplasms

  2023cited by this paper
• The anticancer mechanism of action of selected polyphenols in triple-negative breast cancer (TNBC).

  2023cited by this paper
• Ferulic Acid: A Natural Phenol That Inhibits Neoplastic Events through Modulation of Oncogenic Signaling

  2022influential reference
• Cell cycle regulation: p53-p21-RB signaling

  2022cited by this paper
• Therapeutic Importance of Kaempferol in the Treatment of Cancer through the Modulation of Cell Signalling Pathways

  2022cited by this paper
• Anticancer Effects and Molecular Mechanisms of Apigenin in Cervical Cancer Cells

  2022cited by this paper
• Targeting CDK4 and CDK6 in cancer

  2022cited by this paper
• Baicalein sensitizes triple negative breast cancer MDA-MB-231 cells to doxorubicin via autophagy-mediated down-regulation of CDK1

  2022cited by this paper
• The Promising Therapeutic and Preventive Properties of Anthocyanidins/Anthocyanins on Prostate Cancer

  2022cited by this paper
• Luteolin, a Potent Anticancer Compound: From Chemistry to Cellular Interactions and Synergetic Perspectives

  2022influential reference
• The Potential Role of Apigenin in Cancer Prevention and Treatment

  2022cited by this paper
• Resveratrol and Cervical Cancer: A New Therapeutic Option?

  2022cited by this paper
• Potential roles of genistein in polycystic ovary syndrome: A comprehensive systematic review.

  2022cited by this paper
• Naringenin Induces ROS-Mediated ER Stress, Autophagy, and Apoptosis in Human Osteosarcoma Cell Lines

  2022cited by this paper
• Phytochemicals in Inhibition of Prostate Cancer: Evidence from Molecular Mechanisms Studies

  2022cited by this paper
• CDK inhibitors from past to present: A new wave of cancer therapy.

  2022cited by this paper
• Naringenin: A potential flavonoid phytochemical for cancer therapy.

  2022cited by this paper
• Lignans from the genus Piper L. and their pharmacological activities: An updated review.

  2022cited by this paper
• Current regulatory landscape of nanomaterials and nanomedicines: A global perspective

  2022cited by this paper
• Daidzein and chicory extract arrest the cell cycle via inhibition of cyclin D/CDK4 and cyclin A/CDK2 gene expression in hepatocellular carcinoma.

  2022cited by this paper
• Hallmarks of Cancer: New Dimensions.

  2022cited by this paper
• Apigenin in Cancer Prevention and Therapy: A Systematic Review and Meta-Analysis of Animal Models.

  2022cited by this paper
• Exploring the role of senescence inducers and senotherapeutics as targets for anticancer natural products.

  2022cited by this paper
• Luteolin: a flavonoid with a multifaceted anticancer potential

  2022cited by this paper
• The mechanisms of action of prenylated xanthones against breast, colon, and lung cancers, and their potential application against drug resistance

  2022cited by this paper
• Long-term Survival, Tolerability, and Safety of First-Line Bevacizumab and FOLFIRI in Combination With Ginsenoside-Modified Nanostructured Lipid Carrier Containing Curcumin in Patients With Unresectable Metastatic Colorectal Cancer

  2022cited by this paper
• Cyanidin as potential anticancer agent targeting various proliferative pathways

  2022cited by this paper
• Nobiletin suppresses cholangiocarcinoma proliferation via inhibiting GSK3β

  2022cited by this paper
• Wogonin and its analogs for the prevention and treatment of cancer: A systematic review

  2022cited by this paper
• Apigenin inhibits renal cell carcinoma cell proliferation through G2/M phase cell cycle arrest.

  2022cited by this paper
• The role of polyphenols in overcoming cancer drug resistance: a comprehensive review

  2022cited by this paper
• Nobiletin as a chemopreventive natural product against cancer, a comprehensive review

  2022cited by this paper
• Underlying Anticancer Mechanisms and Synergistic Combinations of Phytochemicals with Cancer Chemotherapeutics: Potential Benefits and Risks

  2022cited by this paper
• Two-Step Synthesis, Structure, and Optical Features of a Double Hetero[7]helicene

  2022cited by this paper
• Hesperidin delays cell cycle progression into the G0/G1 phase via suspension of MAPK signaling pathway in intrahepatic cholangiocarcinoma

  2022cited by this paper
• Advances in Dietary Phenolic Compounds to Improve Chemosensitivity of Anticancer Drugs

  2022cited by this paper
• Syringic acid suppressed proliferation, invasion, and migration via inhibition of matrix metalloproteinases expression on glioblastoma cells by promoting apoptosis.

  2022cited by this paper
• A phase I evaluation of the effect of curcumin on dose‐limiting toxicity and pharmacokinetics of irinotecan in participants with solid tumors

  2022cited by this paper
• Molecular Mechanism of Chrysin in Hepatocellular Carcinoma Treatment Based on Network Pharmacology and in Vitro Experiments

  2021cited by this paper
• The natural flavones, acacetin and apigenin, induce Cdk-Cyclin mediated G2/M phase arrest and trigger ROS-mediated apoptosis in glioblastoma cells

  2021influential reference
• Naringenin inhibits human breast cancer cells (MDA-MB-231) by inducing programmed cell death, caspase stimulation, G2/M phase cell cycle arrest and suppresses cancer metastasis.

  2021cited by this paper
• The role of dietary polyphenols in osteosarcoma: A possible clue about the molecular mechanisms involved in a process that is just in its infancy.

  2021cited by this paper
• Delphinidin induces cell cycle arrest and apoptosis in HER-2 positive breast cancer cell lines by regulating the NF-κB and MAPK signaling pathways

  2021cited by this paper
• Transcriptional cyclin-dependent kinases: Potential drug targets in cancer therapy.

  2021influential reference
• p53 signaling in cancer progression and therapy

  2021cited by this paper
• Inhibiting effect of p-Coumaric acid on U87MG human glioblastoma cell growth

  2021cited by this paper
• Cell cycle control in cancer

  2021cited by this paper
• Apigenin enhances apoptosis induction by 5-fluorouracil through regulation of thymidylate synthase in colorectal cancer cells

  2021cited by this paper
• CDK inhibitors in cancer therapy, an overview of recent development.

  2021cited by this paper
• Cell cycle regulation by complex nanomachines

  2021cited by this paper
• Gallic Acid Hindered Lung Cancer Progression by Inducing Cell Cycle Arrest and Apoptosis in A549 Lung Cancer Cells via PI3K/Akt Pathway

  2021cited by this paper
• Classifications of polyphenols and their potential application in human health and diseases

  2021cited by this paper
• Targeting LIMK1 with luteolin inhibits the growth of lung cancer in vitro and in vivo

  2021cited by this paper
• Cyclin-Dependent Kinases (CDK) and Their Role in Diseases Development–Review

  2021cited by this paper
• Tangeretin as an adjuvant and chemotherapeutic sensitizer against various types of cancers: a comparative overview.

  2021cited by this paper
• Ferulic acid-mediated modulation of apoptotic signaling pathways in cancer.

  2021cited by this paper
• Nobiletin downregulates the SKP2-p21/p27-CDK2 axis to inhibit tumor progression and shows synergistic effects with palbociclib on renal cell carcinoma

  2021cited by this paper
• Curcumin Synergizes with Cisplatin to Inhibit Colon Cancer through Targeting the MicroRNA-137-Glutaminase Axis

  2021cited by this paper
• Kaempferol suppresses proliferation and induces apoptosis and DNA damage in human gallbladder cancer cells through the CDK4/CDK6/cyclin D1 pathway.

  2021cited by this paper
• Syringic acid regulates suppression of the STAT3/JNK/AKT pathway via inhibition of human ovarian teratoma cancer cell (PA‐1) growth—in vitro study

  2021cited by this paper
• Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting.

  2021cited by this paper
• Incipient citrus polymethoxylated flavone Tangeretin as anticancer drug candidate: Mechanistic insights, limitations and possible solutions

  2021cited by this paper
• LINC00261 regulates EBF1 to suppress malignant progression of thyroid cancer.

  2021cited by this paper
• New Oleoyl Hybrids of Natural Antioxidants: Synthesis and In Vitro Evaluation as Inducers of Apoptosis in Colorectal Cancer Cells

  2020cited by this paper
• Polyphenols in cancer prevention: New insights (Review)

  2020influential reference
• The Anti-tumor Effects of p-Coumaric Acid on Melanoma A375 and B16 Cells

  2020cited by this paper
• Resveratrol and Resveratrol-Aspirin Hybrid Compounds as Potent Intestinal Anti-Inflammatory and Anti-Tumor Drugs

  2020cited by this paper
• Genistein Suppresses v-Src-Driven Proliferative Activity by Arresting the Cell-Cycle at G2/M through Increasing p21 Level in Src-Activated Human Gallbladder Carcinoma cells

  2020cited by this paper
• Wogonin Induces Apoptosis and Reverses Sunitinib Resistance of Renal Cell Carcinoma Cells via Inhibiting CDK4-RB Pathway

  2020cited by this paper
• Resveratrol synergizes with cisplatin in antineoplastic effects against AGS gastric cancer cells by inducing endoplasmic reticulum stress-mediated apoptosis and G2/M phase arrest

  2020cited by this paper

• In vitro cytotoxicity of medicinal plants used in prostate cancer management in Africa: a systematic review

  2026cites this paper
• Phenolic Extract of Macrotyloma uniflorum Triggers Caspase 3–Mediated Apoptosis and HDAC Modulation in PC3 Prostate Cancer Cells

  2025cites this paper